CVS Health Gross Margin 2010-2024 | CVS
Current and historical gross margin for CVS Health (CVS) over the last 10 years. The current gross profit margin for CVS Health as of December 31, 2024 is %.
| CVS Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $372.81B | $166.52B | 44.67% |
| 2024-09-30 | $368.91B | $160.47B | 43.50% |
| 2024-06-30 | $363.25B | $153.07B | 42.14% |
| 2024-03-31 | $360.94B | $147.22B | 40.79% |
| 2023-12-31 | $357.78B | $140.68B | 39.32% |
| 2023-09-30 | $347.81B | $136.40B | 39.22% |
| 2023-06-30 | $339.20B | $132.12B | 38.95% |
| 2023-03-31 | $330.92B | $128.08B | 38.70% |
| 2022-12-31 | $322.47B | $125.58B | 38.94% |
| 2022-09-30 | $315.23B | $123.68B | 39.24% |
| 2022-06-30 | $307.86B | $121.67B | 39.52% |
| 2022-03-31 | $299.84B | $119.42B | 39.83% |
| 2021-12-31 | $292.11B | $116.31B | 39.82% |
| 2021-09-30 | $285.06B | $113.18B | 39.71% |
| 2021-06-30 | $278.32B | $110.52B | 39.71% |
| 2021-03-31 | $271.05B | $106.52B | 39.30% |
| 2020-12-31 | $268.71B | $104.73B | 38.97% |
| 2020-09-30 | $266.04B | $102.45B | 38.51% |
| 2020-06-30 | $263.80B | $100.70B | 38.18% |
| 2020-03-31 | $261.89B | $100.07B | 38.21% |
| 2019-12-31 | $256.78B | $98.06B | 38.19% |
| 2019-09-30 | $244.31B | $87.09B | 35.65% |
| 2019-06-30 | $226.99B | $70.71B | 31.15% |
| 2019-03-31 | $210.48B | $54.29B | 25.79% |
| 2018-12-31 | $194.58B | $38.13B | 19.60% |
| 2018-09-30 | $188.56B | $35.00B | 18.56% |
| 2018-06-30 | $187.25B | $34.13B | 18.22% |
| 2018-03-31 | $186.02B | $33.01B | 17.74% |
| 2017-12-31 | $184.79B | $31.34B | 16.96% |
| 2017-09-30 | $182.37B | $30.38B | 16.66% |
| 2017-06-30 | $180.81B | $30.75B | 17.01% |
| 2017-03-31 | $178.85B | $30.84B | 17.24% |
| 2016-12-31 | $177.55B | $31.01B | 17.47% |
| 2016-09-30 | $172.70B | $28.55B | 16.53% |
| 2016-06-30 | $166.73B | $27.72B | 16.63% |
| 2016-03-31 | $160.17B | $27.11B | 16.92% |
| 2015-12-31 | $153.29B | $26.53B | 17.31% |
| 2015-09-30 | $149.20B | $25.86B | 17.33% |
| 2015-06-30 | $145.58B | $25.67B | 17.63% |
| 2015-03-31 | $143.01B | $25.59B | 17.89% |
| 2014-12-31 | $139.37B | $25.37B | 18.20% |
| 2014-09-30 | $135.14B | $25.07B | 18.55% |
| 2014-06-30 | $132.05B | $24.63B | 18.65% |
| 2014-03-31 | $128.70B | $24.15B | 18.76% |
| 2013-12-31 | $126.76B | $23.78B | 18.76% |
| 2013-09-30 | $125.31B | $23.72B | 18.93% |
| 2013-06-30 | $123.61B | $23.34B | 18.89% |
| 2013-03-31 | $123.07B | $22.95B | 18.65% |
| 2012-12-31 | $123.12B | $22.49B | 18.27% |
| 2012-09-30 | $120.04B | $21.77B | 18.13% |
| 2012-06-30 | $116.48B | $21.30B | 18.28% |
| 2012-03-31 | $112.18B | $20.93B | 18.66% |
| 2011-12-31 | $107.08B | $20.56B | 19.20% |
| 2011-09-30 | $103.08B | $20.44B | 19.83% |
| 2011-06-30 | $100.12B | $20.28B | 20.26% |
| 2011-03-31 | $97.71B | $20.22B | 20.69% |
| 2010-12-31 | $95.78B | $20.22B | 21.11% |
| 2010-09-30 | $96.79B | $20.33B | 21.00% |
| 2010-06-30 | $97.72B | $20.32B | 20.80% |
| 2010-03-31 | $98.58B | $20.36B | 20.65% |
| 2009-12-31 | $98.22B | $20.36B | 20.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $85.419B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |